Genetraks raises $6m
Wednesday, 18 December, 2002
Genetraks, a start-up biotech developing blood tests for use in pre-race evaluation of animals such as racehorses, has received a $6 million injection of venture capital.
The commercial potential of its technology for assessing the health of racing animals with a view to maximising their performance has helped the company win investment interest in a difficult market.
The Brisbane company, which received earlier support from St George Innovation Fund and a $246,380 Biotechnology Innovation Fund (BIF) grant, is based on bioinformatics techniques. Its technology relates to the diagnostic capacity of gene expression 'signatures' in white blood cells in immune-mediated diseases.
The company is led by two veterinary PhDs, Rosalyn and Richard Brandon, who respectively are its CEO and biotechnology director.
New molecular mechanism found for depression
Depression may not only result from simple neuronal damage but can also arise from the...
Over-the-counter medications linked to antibiotic resistance
Over-the-counter medications such as ibuprofen and paracetamol are quietly driving antibiotic...
Subtle heart dysfunction detected in young adults with bipolar
A new study reveals that myocardial dysfunction is already evident in patients with bipolar...
